Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
DE. B. Sorafenib ***
DE. B. Sorafenib ***'s subsections
(*) USA Approval Date: 2005. 12.20
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 01.23
Patent>US Expiration: 2018. 05.22
TradeMark
TradeMark Web-Site
DE. B. Sorafenib ***'s products
This section has no products
(*) USA Approval Date: 2005. 12.20
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 01.23
Patent>US Expiration: 2018. 05.22
TradeMark
TradeMark Web-Site